Annual report pursuant to Section 13 and 15(d)

SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details)

v3.23.1
SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Income Tax Disclosure [Abstract]    
Net operating loss carry-forward $ 3,204,894 $ 3,073,065
Accrued expenses 166,783
Stock based compensation 58,106 70,128
Section 174 R&D expenses 193,236
Charitable contribution 221 267
Net deferred tax assets 3,456,457 3,310,243
Valuation allowance (3,456,457) (3,310,243)
Total net deferred tax asset